FIELD: medicine, pharmaceutics.
SUBSTANCE: invention belongs to pharmaceutical industry, notably to aqueous pharmaceutical suspension of zwitterionic dehydrate of fexofenadine .
EFFECT: obtaining of aqueous pharmaceutical suspension of zwitterionic dehydrate of fexofenadine.
93 cl, 4 tbl, 9 ex, 4 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| PHARMACEUTICAL SUSPENSIONS, WHICH DO NOT CONTAIN COLOURING AGENTS, AND METHODS OF OBTAINING THEM | 2005 |
|
RU2395275C2 |
| PREPARATIONS FOR ORAL ADMINISTRATION | 1998 |
|
RU2184570C2 |
| FLUID FORMULATION OF FOLLICLE-STIMULATING HORMONE | 2011 |
|
RU2553375C2 |
| PASTILLE DOZED FORM | 2018 |
|
RU2771806C2 |
| THERAPEUTIC TARGETED FUSION PROTEINS BASED ON LYSOSOMAL ENZYMES, RELEVANT COMPOSITIONS AND THEIR APPLICATIONS | 2017 |
|
RU2751235C2 |
| SUSPENSION COMPOSITIONS OF CYCLOSPORINE A FOR SUBCONJUNCTIVAL AND PERIOCULAR INJECTION | 2015 |
|
RU2713953C2 |
| LIQUID COMPOSITIONS CONTAINING VALSARTAN | 2008 |
|
RU2488393C2 |
| DOSAGE FORM OF ORALLY DISINTEGRATING TWO-PIECE TABLET | 2008 |
|
RU2466719C2 |
| LIQUID NASAL SPRAY CONTAINING LOW-DOSE NALTREXONE | 2011 |
|
RU2552786C2 |
| ORAL SUSPENSION CONTAINING HIGH DOSE OF MOFETIL MYCOPHENOLATE | 1994 |
|
RU2150942C1 |
